Carl Zeiss Meditec AG (OTCMKTS:CZMWY) Receives Average Recommendation of “Hold” from Brokerages

Shares of Carl Zeiss Meditec AG (OTCMKTS:CZMWY) have been assigned an average rating of “Hold” from the six analysts that are currently covering the stock, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation, four have issued a hold recommendation and one has issued a buy recommendation on the company.

CZMWY has been the topic of several analyst reports. Sanford C. Bernstein lowered Carl Zeiss Meditec to a “market perform” rating in a report on Monday. The Goldman Sachs Group lowered shares of Carl Zeiss Meditec from a “buy” rating to a “neutral” rating in a report on Tuesday, January 20th.

Carl Zeiss Meditec Stock Performance

Shares of OTCMKTS:CZMWY opened at $33.22 on Monday. Carl Zeiss Meditec has a 12-month low of $32.59 and a 12-month high of $76.28. The company’s 50 day moving average price is $46.17 and its two-hundred day moving average price is $50.06.

About Carl Zeiss Meditec

Carl Zeiss Meditec AG is a global medical technology company headquartered in Jena, Germany. Founded in 2002 as a spin-off from the Carl Zeiss Group, the business leverages the parent company’s expertise in optics and precision engineering. Over the years, Carl Zeiss Meditec has grown through organic development and strategic acquisitions, becoming a recognized provider of innovative surgical and diagnostic solutions for eye care and microsurgery.

The company’s core offerings span two primary divisions: Ophthalmic Devices and Microsurgery.